Status: Recruiting
Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis
The purpose of this study is to test the safety and efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (UCMSC) for the treatment of Systemic Sclerosis (SSc).
Participants needed: 18
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Marie Hudson, MDUpdated: Feb 3, 2026Locations: 1
Eligibility criteria
SSc according to American College of Rheumatology/European League Against Rheuma... [+2]
Age < 18 years [+15]